NIKE Inc. (NKE)
Buenos Aires Exchange · Argentina · prices in ARS · close of 23 Oct 2026
Key indicators
| Last close | ARS 5,130.00 |
|---|---|
| 52-week range | 4,320.00 – 9,260.00 |
| Return, 1 month / 3 months | +6.8% / −4.9% |
| Return, 1 year / 3 years | −43.2% / −36.8% |
| Trend | Below its 200-day average |
| RSI (14) | 61 |
| Volatility (1 year) | 35.7% |
| Worst drawdown (1 year) | -48.0% |
| Average daily value traded | 828.60M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nike designs, develops and markets athletic footwear, apparel and equipment for athletes and everyday customers around the world. Its product range covers running, basketball, training, football and lifestyle lines, along with sports accessories. The company sells through its own retail stores and online channels as well as through independent retailers and distributors in many countries. Nike is based near Beaverton, Oregon, in the United States, and also owns the Converse brand of casual footwear and clothing.
On this site NIKE Inc. appears as a stock on the Buenos Aires Exchange (Argentina), code NKE, with prices in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NIKE Inc. (NKE) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 5,130.00 on 23 October 2026.
Its price-based Market X-Ray is 35 out of 100 (a weak price profile), ranking 115 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 43.2% and over the last three months it fell 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 17 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.3% | ||
| From 52-week high | -43.2% | ||
| Momentum | 24 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.9% | ||
| 6-month return | -6.9% | ||
| 12-month return, skipping the last month | -46.8% | ||
| Stability (higher is calmer) | 39 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.0% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 828.60M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | +6.8% |
| 3 months | −4.9% |
| 6 months | −6.9% |
| 1 year | −43.2% |
| 3 years | −36.8% |
| 5 years | −52.9% |
Signals
| 50-day / 200-day average | 4,978.60 / 5,920.10 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 149.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Nov 2019 | USD 0.0817 |
| 30 Aug 2019 | USD 0.0733 |
| 31 May 2019 | USD 0.0733 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.